SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001607062-17-000021
Filing Date
2017-01-17
Accepted
2017-01-17 12:28:39
Documents
73
Period of Report
2016-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A gnbt073116form10ka.htm 10-K/A 254634
  Complete submission text file 0001607062-17-000021.txt   3388031

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE gnbt-20160731.xml EX-101.INS 565701
3 XBRL SCHEMA FILE gnbt-20160731.xsd EX-101.SCH 56185
4 XBRL CALCULATION FILE gnbt-20160731_cal.xml EX-101.CAL 42335
5 XBRL DEFINITION FILE gnbt-20160731_def.xml EX-101.DEF 172846
6 XBRL LABEL FILE gnbt-20160731_lab.xml EX-101.LAB 347416
7 XBRL PRESENTATION FILE gnbt-20160731_pre.xml EX-101.PRE 266819
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 000-25169 | Film No.: 17529898
SIC: 2834 Pharmaceutical Preparations